<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cell J</journal-id><journal-id journal-id-type="iso-abbrev">Cell J</journal-id><journal-id journal-id-type="publisher-id">Royan Institute</journal-id><journal-title-group><journal-title>Cell Journal (Yakhteh)</journal-title></journal-title-group><issn pub-type="ppub">2228-5806</issn><issn pub-type="epub">2228-5814</issn><publisher><publisher-name>Royan Institute</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24611142</article-id><article-id pub-id-type="pmc">4204186</article-id><article-id pub-id-type="other">Cell-J-16-367</article-id><article-categories><subj-group subj-group-type="heading"><subject>Short Communication</subject><subj-group><subject>Physiology</subject><subject>Biochemistry</subject></subj-group></subj-group></article-categories><title-group><article-title>Effects of An Eight-Week Resistance Training on Plasma Vaspin
Concentrations, Metabolic Parameters Levels and Physical
Fitness in Patients with Type 2 Diabetes</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Amouzad Mahdirejei</surname><given-names>Hassan</given-names></name><degrees>M.A</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fadaei Reyhan Abadei</surname><given-names>Sajedeh</given-names></name><degrees>M.A</degrees><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Abbaspour Seidi</surname><given-names>Arshin</given-names></name><degrees>M.A</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Eshaghei Gorji</surname><given-names>Negar</given-names></name><degrees>M.A</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rahmani Kafshgari</surname><given-names>Hassan</given-names></name><degrees>M.A</degrees><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Ebrahim Pour</surname><given-names>Mostafa</given-names></name><degrees>B.Sc</degrees><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Bagheri Khalili</surname><given-names>Habib</given-names></name><degrees>B.A</degrees><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Hajeizad</surname><given-names>Farshad</given-names></name><degrees>B.A</degrees><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Khayeri</surname><given-names>Mohamad</given-names></name><degrees>M.A</degrees><xref ref-type="aff" rid="A2">2</xref></contrib><aff id="A1"><label>1</label>Department Of Exercise Physiology, Faculty of Physical Education and Sport Science, Islamic Azad University Sari
Branch, Sari, Iran</aff><aff id="A2"><label>2</label>Physical Education and Sport Science Faculty, Shomal Non-Governmental University, Amol, Iran</aff><aff id="A3"><label>3</label>Department of Exercise Physiology, Faculty of Physical Education and Sport Science, University of Payam Noor
Behshahr Branch, Behshahr, Iran</aff></contrib-group><author-notes><corresp id="cor1"><label>*Corresponding Address:</label><addr-line>P.O.Box: 48519-33544</addr-line><addr-line>Department of Exercise Physiology</addr-line><addr-line>Faculty of Physical Education and Sport Science</addr-line><institution>Islamic Azad University Sari Branch</institution><addr-line>Sari</addr-line><country>Iran</country>
Email:<email>sajedeh.fadaei@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Autumn</season><year>2014</year></pub-date><pub-date pub-type="epub"><day>4</day><month>10</month><year>2014</year></pub-date><volume>16</volume><issue>3</issue><fpage>367</fpage><lpage>374</lpage><history><date date-type="received"><day>5</day><month>6</month><year>2013</year></date><date date-type="accepted"><day>31</day><month>8</month><year>2013</year></date></history><permissions><copyright-statement>Any use, distribution, reproduction or abstract of this publication in any medium, with the exception of commercial purposes, is permitted provided the original work is properly cited</copyright-statement><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><license-p>This is an open-access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
</license-p></license></permissions><abstract><p>Vaspin as a novel adipokine has insulin-sensitizing effects, which may be associated with decreased blood glucose concentration. In this study, we aimed to investigate the effects of resistance exercise training on plasma vaspin concentrations and its relation to plasma levels
of insulin and glucose in patients with type 2 diabetes (T2D). In a quasi-experimental study,
18 male patients with T2D (mean age, 48.50 &#x000b1; 7.73 years, mean weight, 79.41 &#x000b1; 12.60 kg)
were divided into 2 groups as follows: control (n=9), and resistance training (RT; n=9) groups.
Resistance training was performed 3 times weekly for 8 weeks. Anthropometric, metabolic
parameters and plasma vaspin levels were measured at baseline and at the end of study.
Within-group data were analyzed with the paired t test, and between-group effects were analyzed with the independent t test. Waist-hip ratio (WHR), glucose, insulin of plasma and insulin
resistance [homeostasis model assessment of insulin resistance (HOMA-IR) score] were all
significantly decreased, whereas levels of vaspin and plasma lipids [cholesterol, triglycerides
(TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL) and very low-density lipoproteins (VLDL)] showed no significant changes in RT group as compared with the related
values of control groups. Serum vaspin levels did not correlate with anthropometric and metabolic parameters at the assigned times. Our findings suggest that 8-week of resistance training
significantly improved insulin resistance index; however, this form of exercise failed to result in
significant changes in serum vaspin concentration and lipid profiles. Further research is needed
to investigate the role of vaspin in human physiology and to elucidate the effect(s) of exercise
intervention on serum vaspin concentrations (Registration Number: IRCT2013060911772N1). </p></abstract><kwd-group><kwd>Resistance Training</kwd><kwd>Vaspin</kwd><kwd>Lipid</kwd><kwd>Type 2 Diabetes</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>Citation</meta-name><meta-value>Amouzad Mahdirejei H, Fadaei Reyhan Abadei S, Abbaspour Seidi A, Eshaghei Gorji N, Rahmani Kafshgari
H, Ebrahim Pour M, Bagheri Khalili H, Hajeizad F, Khayeri M. Effects of an eight-week resistance training on plasma
vaspin concentrations, metabolic parameters levels and physical fitness in patients with type 2 diabetes. Cell J. 2014;
16(3): 367-374.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>Clinical studies have shown that loss of muscle
mass in individuals with type 2 diabetes (T2D) increases
the risk of developing glucose intolerance
(<xref rid="B1" ref-type="bibr">1</xref>). Also, patients with T2D often experience increases
in adipose tissue (<xref rid="B2" ref-type="bibr">2</xref>). On the other hand,
adipose tissue is a metabolically endocrine organ
that secretes adipocytokines (<xref rid="B3" ref-type="bibr">3</xref>).</p><p>Vaspin identified as a visceral adipose tissuederived
serine protease inhibitor is a novel adipocytokine
that has been suggested as a compensatory
factor against the insulin resistance state of
metabolic syndrome (<xref rid="B3" ref-type="bibr">3</xref>). It has been suggested
that vaspin levels are related to systemic insulin
resistance, indicating possible contribution to the
pathogenesis of diabetes (<xref rid="B4" ref-type="bibr">4</xref>). Youn et al. (<xref rid="B4" ref-type="bibr">4</xref>) reported
that vaspin levels are higher in individuals
with impaired insulin sensitivity. Oberbach et
al. (<xref rid="B5" ref-type="bibr">5</xref>) observed a significant reduction in serum vaspin concentrations after an hour acute exercise
bout as well as after 4 weeks of training, concluding
exercise-induced oxidative stress reduces vaspin serum
concentrations, but this type of exercise fails to
make any improvement in insulin sensitivity. However,
the effects of insulin resistance and lipid profile
changes, induced by resistance training (RT) exercise,
on plasma vaspin concentrations in patients with T2D
are yet unclear. Thus, the aim of the present study was
to investigate the effects of RT exercise on vaspin and
lipid profile levels and to evaluate the possible relationship
between metabolic parameters and plasma
vaspin concentrations in patients with T2D.</p><p>Eighteen adult men with T2D participated in this
quasi-experimental study. Subjects were assigned
to RT group (mean age, 47.60 &#x000b1; 7.7 years; mean
weight=79.5 &#x000b1; 15.4 kg, n=9) and control group (mean
age, 49.62 &#x000b1; 8.05 years, mean weight=79.3 &#x000b1; 8.8,
n=9). This study was approved by the Ethics Committee
of Islamic Azad University of Sari Branch.
Furthermore, all participants signed an informed
consent form. Subjects were excluded if they had a
known history of stroke or transient ischemic attack,
uncontrolled hypertension, severe dyslipidemia, acute
or chronic inflammatory disease, or any other serious
diseases. To reduce drug effects, we selected subjects
with glycated hemoglobin values under 9% who received
over 1,000 mg of metformin per day, and drug
dosages were maintained throughout the study. Before
initiating the tests, the participants underwent familiarization
sessions and participated in one-repetition
maximum (1-RM) test. To estimate the 1-RM, three
days prior to the experiment, participants underwent
1-RM test for the following exercises: bench press,
butterfly, lat pull-down, biceps curl, triceps extension,
seated rowing, knee flexion, knee extension, and heel
raise (<xref rid="B6" ref-type="bibr">6</xref>).</p><p>The RT groups participated in an 8-week (on 3 nonconsecutive
days per week) of supervised circuit resistance
exercise program. The programs were composed
of three following steps: warm-up for 10-15
minutes, circuit resistance exercise for 45-60 minutes,
and cool down for 10 minutes. Resistance exercise
program consisting of 10 isotonic exercises with 50-
80% of 1-RM were performed in a circuit. During the
.rst and fourth weeks of training, the resistance was
set at 50-70% of each individual&#x02019;s 1-RM with 8-15
repetitions of each exercise movement within 45-60
seconds. Thereafter, the goal was to achieve between
70-80% of the current 1-RM with 8-10 repetitions of
each exercise movement within 45-60 seconds. The
participants performed 3 circuits of 10 exercises per
session of training. The intervals between each exercise
were 30-60 seconds and between each circuit
was 120-180 seconds. Ten exercises were used for
training (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>). Blood samples were collected in the
morning after the 12-hour overnight fast, before and
after an 8-week of exercise program. Plasma vaspin
levels were determined with vaspin enzyme-linked
immunosorbent assay (ELISA) kit (Cusabio Biotech,
Wuhan, China). Serum triglyceride (TG), total cholesterol
(TC), high density lipoprotein (HDL), and
very low density lipoprotein (VLDL) were measured
by an enzymatic photometric analyzer (Pars
Azmoun, Tehran, Iran), while low density lipoprotein
(LDL) was determined using a modified version
of the Friedewald formula (FF) (<xref rid="B9" ref-type="bibr">9</xref>). Plasma glucose
was determined using glucose oxidase-peroxidase/4-
aminoantipyrine (GOD-PAP) method (Pars Azmoun,
Tehran, Iran). Serum insulin concentrations were
determined by ELISA kit (Mercodia, Uppsala, Sweden).
Hemoglobin A1C (HbA1C) levels were measured
by enzymatic and chromatographic methods
using commercial kits (Bio-system S.A., Germany).
Insulin resistance was determined by calculating the
homeostasis model assessment of insulin resistance
(HOMA-IR) score using the following formula (<xref rid="B8" ref-type="bibr">8</xref>):</p><disp-formula id="E1"><mml:math id="M1"><mml:mi>HOMA-IR</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo>[</mml:mo><mml:mi>Insulin (U/l)</mml:mi><mml:mo>&#x000d7;</mml:mo><mml:mi>Fasting blood glucose (mmol/l)</mml:mi><mml:mo>]</mml:mo></mml:mrow><mml:mn>22.5</mml:mn></mml:mfrac></mml:math></disp-formula><p>All data were expressed as mean &#x000b1; standard deviations
(SD) and were analyzed using Statistical Package
for the Social Sciences (SPSS, SPSS Inc., Chicago,
IL, USA) version 15.0. The differences between two
groups were examined by an independent samples t
test, while the before and the after comparisons within
group were performed using paired t-tests. The relation
between variables was assessed using Pearson&#x02019;s
method. A p value under 0.05 was considered statistically
significant in the interpretation of the results.</p><p>Metabolic parameters, vaspin levels, anthropometric
and muscle strength performance characteristics
of all participants are demonstrated in tables 1 and
2, at baseline and at the end of study. There are no
significant differences between two groups regarding
anthropometric characteristics, muscle strength
performance, metabolic parameters (TC, TG, HDL,
LDL, VLDL, and HbA1C), and vaspin levels (Tables<xref ref-type="table" rid="T1">1</xref>, <xref ref-type="table" rid="T2">2</xref>). Since glucose, insulin and HOMA-IR levels decreased
significantly, there are significant differences
regarding these values between two groups.</p><p>Also, our findings confirmed that there is no correlation
between vaspin levels with insulin sensitivity,
glucose tolerance and lipid profiles in preand
post-exercise, shown in table 3.</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><p> Anthropometric and muscle strength performance characteristics before and after 8 weeks of training programs</p></caption><table frame="hsides" rules="groups"><tbody><tr><th colspan="5" rowspan="1"><hr/></th></tr><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="left" rowspan="1" colspan="1">Group</th><th align="left" rowspan="1" colspan="1">Baseline</th><th align="left" rowspan="1" colspan="1">8 weeks</th><th align="left" rowspan="1" colspan="1">P value</th></tr><tr><th colspan="5" rowspan="1"><hr/></th></tr><tr><td align="left" rowspan="2" colspan="1">Age (Y)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">47.60 &#x000b1; 7.7</td><td rowspan="1" colspan="1">-</td><td rowspan="2" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">49.62 &#x000b1; 8.05</td><td rowspan="1" colspan="1">-</td></tr><tr><td align="left" colspan="5" rowspan="1">Anthropometric measurement</td></tr><tr><td align="left" rowspan="2" colspan="1">Height (cm)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">169.19 &#x000b1; 7.95</td><td rowspan="1" colspan="1">-</td><td rowspan="2" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">172.81 &#x000b1; 6.45</td><td rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="2" colspan="1">Weight (kg)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">79.5 &#x000b1; 15.4</td><td rowspan="1" colspan="1">80.4 &#x000b1; 14.4</td><td rowspan="2" colspan="1">0.93</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">79.3 &#x000b1; 8.8</td><td rowspan="1" colspan="1">80.3 &#x000b1; 9.1</td></tr><tr><td align="left" rowspan="2" colspan="1">BMI (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">28.0 &#x000b1; 4.9</td><td rowspan="1" colspan="1">26.9 &#x000b1; 4.5</td><td rowspan="2" colspan="1">0.38</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">26.3 &#x000b1; 3.7</td><td rowspan="1" colspan="1">26.4 &#x000b1; 3.7</td></tr><tr><td align="left" rowspan="2" colspan="1">BFP (%)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">22.1 &#x000b1; 3.0</td><td rowspan="1" colspan="1">23.1 &#x000b1; 3.2</td><td rowspan="2" colspan="1">0.27</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">24.5 &#x000b1; 4.4</td><td rowspan="1" colspan="1">23.3 &#x000b1; 4.6</td></tr><tr><td align="left" rowspan="2" colspan="1">WHR</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">0.91 &#x000b1; 0.22</td><td rowspan="1" colspan="1">0.86 &#x000b1; 0.22 *</td><td rowspan="2" colspan="1">0.05 **</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">0.75 &#x000b1; 0.09</td><td rowspan="1" colspan="1">0.75 &#x000b1; 0.09</td></tr><tr><td align="left" rowspan="2" colspan="1">VO<sub>2</sub>max ( ml/kg/min)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">26.16 &#x000b1; 1.15</td><td rowspan="1" colspan="1">32.08 &#x000b1; 1.41 *</td><td rowspan="2" colspan="1">0.04 **</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">29.53 &#x000b1; 1.17</td><td rowspan="1" colspan="1">27.40 &#x000b1; 1.39</td></tr><tr><td align="left" colspan="5" rowspan="1">Muscle strength performance</td></tr><tr><td align="left" rowspan="2" colspan="1">1-RM bench press (kg)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">51.4 &#x000b1; 8.4</td><td rowspan="1" colspan="1">84.4 &#x000b1; 10.7 *</td><td rowspan="2" colspan="1">0.00 **</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">49.48 &#x000b1; 27.7</td><td rowspan="1" colspan="1">36.7 &#x000b1; 3.9</td></tr><tr><td align="left" rowspan="2" colspan="1">1-RM knee extension (kg)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">64.4 &#x000b1; 9.5</td><td rowspan="1" colspan="1">85.3 &#x000b1; 12.5 *</td><td rowspan="2" colspan="1">0.00 **</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">51.4 &#x000b1; 14.9</td><td rowspan="1" colspan="1">56.1 &#x000b1; 6.8</td></tr><tr><td align="left" rowspan="2" colspan="1">1-RM lat pull-down (kg)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">73.4 &#x000b1; 16.6</td><td rowspan="1" colspan="1">94.1 &#x000b1; 13.2 *</td><td rowspan="2" colspan="1">0.00 **</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">42.9 &#x000b1; 4.5</td><td rowspan="1" colspan="1">45.6 &#x000b1; 3.8 *</td></tr><tr><td align="left" rowspan="2" colspan="1">1-RM triceps extension (kg)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">64.4 &#x000b1; 9.5</td><td rowspan="1" colspan="1">85.3 &#x000b1; 12.5 *</td><td rowspan="2" colspan="1">0.04 **</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">51.4 &#x000b1; 14.9</td><td rowspan="1" colspan="1">56.1 &#x000b1; 6.8</td></tr><tr><td align="left" rowspan="2" colspan="1">1-RM heel raise (kg)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">132.3 &#x000b1; 33.3</td><td rowspan="1" colspan="1">179.3 &#x000b1; 32.4 *</td><td rowspan="2" colspan="1">0.00 **</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">115.3 &#x000b1; 13.9</td><td rowspan="1" colspan="1">121.1 &#x000b1; 10.7 *</td></tr><tr><td align="left" rowspan="2" colspan="1">1-RM arm curl (kg)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">59.3 &#x000b1; 5</td><td rowspan="1" colspan="1">85.3 &#x000b1; 12.5 *</td><td rowspan="2" colspan="1">0.10</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">60 &#x000b1; 1.51</td><td rowspan="1" colspan="1">71.5 &#x000b1; 20.9</td></tr><tr><td align="left" rowspan="2" colspan="1">1-RM butterfly (kg)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">65.5 &#x000b1; 9.4</td><td rowspan="1" colspan="1">92.8 &#x000b1; 6.5 *</td><td rowspan="2" colspan="1">0.00 **</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">56.9 &#x000b1; 3.2</td><td rowspan="1" colspan="1">58.6 &#x000b1; 2.8</td></tr><tr><td align="left" rowspan="2" colspan="1">1-RM knee flexion (kg)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">53.6 &#x000b1; 10.2</td><td rowspan="1" colspan="1">91.5 &#x000b1; 9.6 *</td><td rowspan="2" colspan="1">0.00 **</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">58.6 &#x000b1; 2.2</td><td rowspan="1" colspan="1">58.3 &#x000b1; 6.1</td></tr><tr><td align="left" rowspan="2" colspan="1">1-RM crunch</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">26.5 &#x000b1; 12.1</td><td rowspan="1" colspan="1">43.4 &#x000b1; 8.6 *</td><td rowspan="2" colspan="1">0.00 **</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">21 &#x000b1; 3.9</td><td rowspan="1" colspan="1">23.3 &#x000b1; 6.2</td></tr><tr><td align="left" rowspan="2" colspan="1">1-RM seated rowing (kg)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">108 &#x000b1; 14</td><td rowspan="1" colspan="1">133.3 &#x000b1; 10.5 *</td><td rowspan="2" colspan="1">0.10</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">79 &#x000b1; 19.9</td><td rowspan="1" colspan="1">93.3 &#x000b1; 6.2 *</td></tr><tr><th colspan="5" rowspan="1"><hr/></th></tr></tbody></table><table-wrap-foot><fn><p>The values are presented as mean &#x000b1; standard deviation (SD). *; Significant differences within groups at (p&#x02264;0.05) show, **; Significantly differences between groups (p &#x02264; 0.05) show, BMI; Body mass index, BFP; Body fat percentage, WHR; Waist-hip ratio and 1-RM; One-repetition maximum.
</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><p> Metabolic parameters and vaspin levels before and after 8 weeks of training programs</p></caption><table frame="hsides" rules="groups"><tbody><tr><th colspan="5" rowspan="1"><hr/></th></tr><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="left" rowspan="1" colspan="1">Group</th><th align="left" rowspan="1" colspan="1">Baseline</th><th align="left" rowspan="1" colspan="1">8 weeks</th><th align="left" rowspan="1" colspan="1">P value</th></tr><tr><th colspan="5" rowspan="1"><hr/></th></tr><tr><td align="left" rowspan="2" colspan="1">Vaspin (ng/ml)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">319.50 &#x000b1; 75.75</td><td rowspan="1" colspan="1">283.40 &#x000b1; 133.67</td><td rowspan="2" colspan="1">0.380</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">353.75 &#x000b1; 31.90</td><td rowspan="1" colspan="1">391 &#x000b1; 194.72</td></tr><tr><td align="left" rowspan="2" colspan="1">TC (mg/dL)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">180 &#x000b1; 55.51</td><td rowspan="1" colspan="1">171.10 &#x000b1; 37.91</td><td rowspan="2" colspan="1">0.72</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">176.50 &#x000b1; 31.78</td><td rowspan="1" colspan="1">160.87 &#x000b1; 28.33</td></tr><tr><td align="left" rowspan="2" colspan="1">TG (mg/dL)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">175.80 &#x000b1; 72.44</td><td rowspan="1" colspan="1">174.9 &#x000b1; 84.60</td><td rowspan="2" colspan="1">0.08</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">196.75 &#x000b1; 75.24</td><td rowspan="1" colspan="1">132.87 &#x000b1; 44.99</td></tr><tr><td align="left" rowspan="2" colspan="1">HDL-C (mg/dL)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">39.20 &#x000b1; 9.65</td><td rowspan="1" colspan="1">42.80 &#x000b1; 8.87 *</td><td rowspan="2" colspan="1">0.72</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">40.25 &#x000b1; 12.63</td><td rowspan="1" colspan="1">41.93 &#x000b1; 8.21</td></tr><tr><td align="left" rowspan="2" colspan="1">LDL-C (mg/dL)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">83.40 &#x000b1; 26.95</td><td rowspan="1" colspan="1">88.60 &#x000b1; 28.72</td><td rowspan="2" colspan="1">0.39</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">92 &#x000b1; 23.07</td><td rowspan="1" colspan="1">106.50 &#x000b1; 22.36</td></tr><tr><td align="left" rowspan="2" colspan="1">VLDL-C (mg/dL)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">35.16 &#x000b1; 14.48</td><td rowspan="1" colspan="1">34.98 &#x000b1; 16.92</td><td rowspan="2" colspan="1">0.08</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">39.35 &#x000b1; 15.04</td><td rowspan="1" colspan="1">26.57 &#x000b1; 8.99</td></tr><tr><td align="left" rowspan="2" colspan="1">FBS (mg/dL)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">187.40 &#x000b1; 42.06</td><td rowspan="1" colspan="1">164.40 &#x000b1; 48.26</td><td rowspan="2" colspan="1">0.040 **</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">153.25 &#x000b1; 24.24</td><td rowspan="1" colspan="1">159.12 &#x000b1; 27.22</td></tr><tr><td align="left" rowspan="2" colspan="1">Insulin (&#x003bc;U/mL)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">16.77 &#x000b1; 13.14</td><td rowspan="1" colspan="1">8.12 &#x000b1; 3.78 *</td><td rowspan="2" colspan="1">0.021 **</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">17.78 &#x000b1; 5.77</td><td rowspan="1" colspan="1">20.62 &#x000b1; 12.67</td></tr><tr><td align="left" rowspan="2" colspan="1">HOMA-IR</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">7.77 &#x000b1; 6.43</td><td rowspan="1" colspan="1">3.32 &#x000b1; 1.87 *</td><td rowspan="2" colspan="1">0.011 **</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">6.93 &#x000b1; 3.16</td><td rowspan="1" colspan="1">8.15 &#x000b1; 5.37</td></tr><tr><td align="left" rowspan="2" colspan="1">HbA1C (%)</td><td rowspan="1" colspan="1">RT</td><td rowspan="1" colspan="1">8.33 &#x000b1;1.73</td><td rowspan="1" colspan="1">8 &#x000b1; 1.25</td><td rowspan="2" colspan="1">0.07</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">7.58 &#x000b1; 1.51</td><td rowspan="1" colspan="1">8.6 &#x000b1; 1.35</td></tr><tr><th colspan="5" rowspan="1"><hr/></th></tr></tbody></table></table-wrap><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><p> Pearson&#x02019;s correlation coefficients between plasma vaspin concentration and other parameters at baseline and end of programs</p></caption><table frame="hsides" rules="groups"><tbody><tr><th colspan="5" rowspan="1"><hr/></th></tr><tr><th align="left" rowspan="2" colspan="1">Variables</th><th align="left" colspan="2" rowspan="1">Baseline</th><th align="left" colspan="2" rowspan="1">After 8 weeks</th></tr><tr><th align="left" rowspan="1" colspan="1">r</th><th align="left" rowspan="1" colspan="1">P value</th><th align="left" rowspan="1" colspan="1">r</th><th align="left" rowspan="1" colspan="1">P value</th></tr><tr><th colspan="5" rowspan="1"><hr/></th></tr><tr><td align="left" rowspan="1" colspan="1">Body weight (kg)</td><td rowspan="1" colspan="1">0.903</td><td rowspan="1" colspan="1">0.31</td><td rowspan="1" colspan="1">0.301</td><td rowspan="1" colspan="1">0.225</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1">0.482</td><td rowspan="1" colspan="1">0.177</td><td rowspan="1" colspan="1">0.135</td><td rowspan="1" colspan="1">0.594</td></tr><tr><td align="left" rowspan="1" colspan="1">BFP (%)</td><td rowspan="1" colspan="1">0.397</td><td rowspan="1" colspan="1">0.213</td><td rowspan="1" colspan="1">0.197</td><td rowspan="1" colspan="1">0.319</td></tr><tr><td align="left" rowspan="1" colspan="1">WHR</td><td rowspan="1" colspan="1">0.630</td><td rowspan="1" colspan="1">0.122</td><td rowspan="1" colspan="1">0.111</td><td rowspan="1" colspan="1">0.660</td></tr><tr><td align="left" rowspan="1" colspan="1">TC (mg/dL)</td><td rowspan="1" colspan="1">0.328</td><td rowspan="1" colspan="1">0.2444</td><td rowspan="1" colspan="1">0.451</td><td rowspan="1" colspan="1">0.190</td></tr><tr><td align="left" rowspan="1" colspan="1">TG (mg/dL)</td><td rowspan="1" colspan="1">0.611</td><td rowspan="1" colspan="1">0.128</td><td rowspan="1" colspan="1">0.344</td><td rowspan="1" colspan="1">0.237</td></tr><tr><td align="left" rowspan="1" colspan="1">HDL-C (mg/dL)</td><td rowspan="1" colspan="1">0.140</td><td rowspan="1" colspan="1">0.362</td><td rowspan="1" colspan="1">0.394</td><td rowspan="1" colspan="1">0.214</td></tr><tr><td align="left" rowspan="1" colspan="1">LDL-C (mg/dL)</td><td rowspan="1" colspan="1">0.070</td><td rowspan="1" colspan="1">0.437</td><td rowspan="1" colspan="1">0.102</td><td rowspan="1" colspan="1">0.397</td></tr><tr><td align="left" rowspan="1" colspan="1">VLDL-C (mg/dL)</td><td rowspan="1" colspan="1">0.611</td><td rowspan="1" colspan="1">0.128</td><td rowspan="1" colspan="1">0.241</td><td rowspan="1" colspan="1">0.291</td></tr><tr><td align="left" rowspan="1" colspan="1">FBS (mg/dl)</td><td rowspan="1" colspan="1">0.331</td><td rowspan="1" colspan="1">0.243</td><td rowspan="1" colspan="1">0.197</td><td rowspan="1" colspan="1">0.433</td></tr><tr><td align="left" rowspan="1" colspan="1">Insulin (mU.L)</td><td rowspan="1" colspan="1">0.235</td><td rowspan="1" colspan="1">0.295</td><td rowspan="1" colspan="1">0.253</td><td rowspan="1" colspan="1">0.310</td></tr><tr><td align="left" rowspan="1" colspan="1">HOMA-IR</td><td rowspan="1" colspan="1">0.455</td><td rowspan="1" colspan="1">0.188</td><td rowspan="1" colspan="1">0.268</td><td rowspan="1" colspan="1">0.282</td></tr><tr><td align="left" rowspan="1" colspan="1">HbA1C</td><td rowspan="1" colspan="1">0.732</td><td rowspan="1" colspan="1">0.903</td><td rowspan="1" colspan="1">0.345</td><td rowspan="1" colspan="1">0.161</td></tr><tr><th colspan="5" rowspan="1"><hr/></th></tr></tbody></table></table-wrap><p>In the current study, we found a significant
improvement in insulin resistance without any
changes in vaspin and lipid profile concentration.
Vaspin circulating levels are likely to reflect its
expression in the adipose tissue, while there are
several reporters shown vaspin is sex- dependent
and its level is related to body mass index (BMI),
to parameters of insulin sensitivity, and to glucose
metabolism in humans (<xref rid="B3" ref-type="bibr">3</xref>). Kloting et al. (<xref rid="B10" ref-type="bibr">10</xref>) reported
that vaspin mRNA expression is higher in
diabetic patients than in NGT individuals. However,
no difference was found in serum vaspin
level between diabetic patients and normal glucose
tolerance (NGT) subjects in other studies (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B11" ref-type="bibr">11</xref>).
Youn et al. (<xref rid="B4" ref-type="bibr">4</xref>) reported that physical training for 4
weeks in untrained individuals (men and women)
causes increased serum vaspin concentrations with
weight loss. On the other hand, Oberbach et al. (<xref rid="B5" ref-type="bibr">5</xref>)
reported a significant reduction in serum vaspin
concentrations after one hour acute aerobic exercise
bout in healthy young men, concluding exercise-
induced oxidative stress reduces vaspin serum
concentrations. However, the result from the
current study is in agreement with recent studies in
which they found no changes in vaspin concentration
after lifestyle modification in adults (<xref rid="B12" ref-type="bibr">12</xref>). To
our knowledge, only Oberbach et al. (<xref rid="B5" ref-type="bibr">5</xref>) has investigated
response of vaspin after an acute bout of exercise. It seems that the differences between the
results found in the present study and those reported
by Oberbach et al. (<xref rid="B5" ref-type="bibr">5</xref>) may be related to the type
of exercise (resistance vs. endurance), suggesting
that vaspin serum concentrations are decreased by
exercise-induced oxidative stress, confirmed by
present study. Also, it seems that it could be due
to difference in age of participants of these studies.
Different growth stages (ages) could affect levels
of growth hormone (GH). In a study by Gonzalez
et al. (<xref rid="B13" ref-type="bibr">13</xref>), they have shown that circulating GH
concentrations increased vaspin circulating levels
and its expression. Knowing that most of our subjects
are elderly men with large variation in GH
levels, this could explain the large variation of
vaspin levels between two groups.</p><p>In agreement with previous studies about middle-
aged patients with T2D (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B15" ref-type="bibr">15</xref>), in this study,
our training program induced a marked increase
in HDL levels in RT group without any significant
modification in other variables of the lipid profile.
RT is recommended by the American College of
Sports Medicine (<xref rid="B16" ref-type="bibr">16</xref>) and the American Diabetes
Association (<xref rid="B17" ref-type="bibr">17</xref>) as an effective tool to prevent and
to treat metabolic diseases. Low HDL and high TG
levels have been reported in males with T2D (<xref rid="B18" ref-type="bibr">18</xref>,
<xref rid="B19" ref-type="bibr">19</xref>). Also, T2D patients with serum TG above 2.3
mmol/l have a 2-fold increased risk of coronary
heart disease (CHD) (<xref rid="B19" ref-type="bibr">19</xref>). In addition, low levels
of physical activity and cardiorespiratory fitness
are independent risk factors of CHD in the general
population. Improvement in physical fitness
has been shown to induce health benefits in term
of morbidity, mortality and improvement in CHD
risk factors such as visceral adipose tissue and
hypertriglyceridemia (<xref rid="B20" ref-type="bibr">20</xref>). There is also a 2-year
study showing a slight increase in HDL-cholesterol
levels with exercise, but its mechanism is yet
unknown (<xref rid="B21" ref-type="bibr">21</xref>). Those studies showing increased
HDL generally involved more rigorous training
regimens (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>), although there is some disagreement
on this point as well (<xref rid="B24" ref-type="bibr">24</xref>). To consider
the fact that our study demonstrated an increase
in HDL level in the treatment group, our findings
indicates that our subjects may exercise at high
intensity. Although there is some suggestion that
men with low HDL levels are less likely to respond
to training than men with higher HDL levels (<xref rid="B25" ref-type="bibr">25</xref>),
our data support this concept.</p><p>In the current study, we found a significant improvement
in insulin resistance without any
changes in vaspin concentration. Insulin resistance
means an impaired biological response to
insulin by one or more of its target tissues, leading
to a reduction in glucose disposal rate (<xref rid="B8" ref-type="bibr">8</xref>).
Relationship between exercise training with
prevention and management of T2D has a long
history (<xref rid="B26" ref-type="bibr">26</xref>). Earlier studies suggested that resistance
training, similar to endurance training,
could improve insulin resistance as well (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B26" ref-type="bibr">26</xref>).
It is reported that physical activity increases the
amount of GLUT4 which is associated with glucose
uptake in skeletal muscle tissue (<xref rid="B26" ref-type="bibr">26</xref>). The
results of the present study show that after resistance
exercise, plasma levels of glucose and
insulin significantly decreased. In the study conducted
by Jurimae et al. (<xref rid="B27" ref-type="bibr">27</xref>), they observed no
changes in insulin concentrations after 6,000
m rowing ergometer test in highly trained male
rowers, while glucose levels were significantly
increased after the exercise and decreased after
the first 30 minutes of recovery. In another study,
Jamurtas et al. (<xref rid="B28" ref-type="bibr">28</xref>) reported that after 45 minutes
of sub-maximal aerobic exercise with 65%
of maximal oxygen consumption, overweight
males showed an increase in insulin sensitivity
and a significant decrease in insulin concentration,
only immediately after exercise. There is
considerable inter-individual variability in the
metabolic response to resistance exercise and the
concomitant changes in glucose and insulin dynamics
(<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B30" ref-type="bibr">30</xref>).</p><p>In conclusion, this study showed that RT significantly
decreased levels of glucose, insulin and
HOMA-IR in elderly patients with T2D. However,
this form of exercise failed to result in significant
changes in serum vaspin concentration and lipid
profiles. We found no association between changes
in serum vaspin concentrations and changes in
plasma levels of insulin and glucose to confirm the
possible role of vaspin as a regulator of glucose
metabolism. Further studies are needed to investigate
the role of vaspin in human physiology and
to elucidate the contradictory results regarding the
effect(s) of exercise intervention on serum vaspin
concentration.</p><p>The current study has some limitations. The
study population was relatively small; however,
the study had sufficient power to detect the influence
of RT complications on serum vaspin levels.</p><p>Furthermore, a group of men were only included
in our study, so we were not able to extrapolate the
conclusions to the entire population. Finally, short
exercise intervention with no long term follow-up,
no specific diet, and no changes in other lifestyle
associated physical activity were included in our
exercise training period.</p></body><back><ack><p>Authors appreciated the all participants for
their cooperation in this study. This research
was financially supported by Islamic Azad University
Sari Branch, Sari, Iran. The authors declare
that there is no conflict of interest in this
article. The authors declare that there is no conflict
of interest in this article.</p></ack><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strasser</surname><given-names>B</given-names></name><name><surname>Siebert</surname><given-names>U</given-names></name><name><surname>Schobersberger</surname><given-names>W</given-names></name></person-group><article-title>Resistance training in the treatment of the metabolic syndrome: a systematic review andmeta-analysis of the effect of resistance training on metabolic clustering in patients with abnormal glucosemetabolism</article-title><source>Sports Med</source><year>2010</year><volume>40</volume><issue>5</issue><fpage>397</fpage><lpage>415</lpage><pub-id pub-id-type="pmid">20433212</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoico</surname><given-names>E</given-names></name><name><surname>Di Francesco</surname><given-names>V</given-names></name><name><surname>Mazzali</surname><given-names>G</given-names></name><name><surname>Vettor</surname><given-names>R</given-names></name><name><surname>Fantin</surname><given-names>F</given-names></name><name><surname>Bissoli</surname><given-names>L</given-names></name><etal/></person-group><article-title>Adipocytokines, fat distribution, and insulin resistance in elderly men and women</article-title><source>J Gerontol A Biol Sci Med Sci</source><year>2004</year><volume>59</volume><issue>9</issue><fpage>M935</fpage><lpage>M939</lpage><pub-id pub-id-type="pmid">15472159</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulcelik</surname><given-names>NE</given-names></name><name><surname>Karakaya</surname><given-names>J</given-names></name><name><surname>Gedik</surname><given-names>A</given-names></name><name><surname>Usman</surname><given-names>A</given-names></name><name><surname>Gurlek</surname><given-names>A</given-names></name></person-group><article-title>Serum vaspin levels in type 2 diabetic women in relation to microvascular complications</article-title><source>Eur J Endocrinol</source><year>2009</year><volume>160</volume><issue>1</issue><fpage>65</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">18952766</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Youn</surname><given-names>BS</given-names></name><name><surname>Kl&#x000f6;ting</surname><given-names>N</given-names></name><name><surname>Kratzsch</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>N</given-names></name><name><surname>Park</surname><given-names>JW</given-names></name><name><surname>Song</surname><given-names>ES</given-names></name></person-group><article-title>Serum vaspin concentrations in human obesity and type 2 diabetes</article-title><source>Diabetes</source><year>2008</year><volume>57</volume><issue>2</issue><fpage>372</fpage><lpage>377</lpage><pub-id pub-id-type="pmid">17991760</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oberbach</surname><given-names>A</given-names></name><name><surname>Kirsch</surname><given-names>K</given-names></name><name><surname>Lehmann</surname><given-names>S</given-names></name><name><surname>Schlichting</surname><given-names>N</given-names></name><name><surname>Fasshauer</surname><given-names>M</given-names></name><name><surname>Zarse</surname><given-names>K</given-names></name><etal/></person-group><article-title>Serum vaspin concentrations are decreased after exercise-induced oxidative stress</article-title><source>Obes Facts</source><year>2010</year><volume>3</volume><issue>5</issue><fpage>328</fpage><lpage>331</lpage><pub-id pub-id-type="pmid">20975299</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazzeo</surname><given-names>RS</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name></person-group><article-title>Exercise prescription for the elderly: current recommendations</article-title><source>Sports Med</source><year>2001</year><volume>31</volume><issue>11</issue><fpage>809</fpage><lpage>818</lpage><pub-id pub-id-type="pmid">11583105</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunstan</surname><given-names>DW</given-names></name><name><surname>Daly</surname><given-names>RM</given-names></name><name><surname>Owen</surname><given-names>N</given-names></name><name><surname>Jolley</surname><given-names>D</given-names></name><name><surname>De Courten</surname><given-names>M</given-names></name><name><surname>Shaw</surname><given-names>J</given-names></name><etal/></person-group><article-title>High-intensity resistence traning improves glycemic control in older patients with type 2 diabetes</article-title><source>Diabetes Care</source><year>2002</year><volume>25</volume><issue>10</issue><fpage>1729</fpage><lpage>1736</lpage><pub-id pub-id-type="pmid">12351469</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colberg</surname><given-names>SR</given-names></name><name><surname>Sigal</surname><given-names>RJ</given-names></name><name><surname>Fernhall</surname><given-names>B</given-names></name><name><surname>Regensteiner</surname><given-names>JG</given-names></name><name><surname>Blissmer</surname><given-names>BJ</given-names></name><name><surname>Rubin</surname><given-names>RR</given-names></name><etal/></person-group><article-title>Exercise and type 2 diabetes: The American College of Sports Medicine and the American Diabetes Association: joint position statement</article-title><source>Diabetes Care</source><year>2010</year><volume>33</volume><issue>12</issue><fpage>e147</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">21115758</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>JC</given-names></name><name><surname>Matthews</surname><given-names>DR</given-names></name><name><surname>Hermans</surname><given-names>MP</given-names></name></person-group><article-title>Correct homeostasis model assessment (HOMA) evaluation uses the computer program</article-title><source>Diabetes Care</source><year>1998</year><volume>21</volume><issue>12</issue><fpage>2191</fpage><lpage>2192</lpage><pub-id pub-id-type="pmid">9839117</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kloting</surname><given-names>N</given-names></name><name><surname>Berndt</surname><given-names>J</given-names></name><name><surname>Kralisch</surname><given-names>S</given-names></name><name><surname>Kovacs</surname><given-names>P</given-names></name><name><surname>Fasshauer</surname><given-names>M</given-names></name><name><surname>Sch&#x000f6;n</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes</article-title><source>Biochem Biophys Res Commun</source><year>2006</year><volume>339</volume><issue>1</issue><fpage>430</fpage><lpage>436</lpage><pub-id pub-id-type="pmid">16298335</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulcelik</surname><given-names>NE</given-names></name><name><surname>Karakaya</surname><given-names>J</given-names></name><name><surname>Gedik</surname><given-names>A</given-names></name><name><surname>Usman</surname><given-names>A</given-names></name><name><surname>Gurlek</surname><given-names>A</given-names></name></person-group><article-title>Serum vaspin levels in type 2 diabetic women in relation to microvascular complications</article-title><source>Eur J Endocrinol</source><year>2009</year><volume>160</volume><issue>1</issue><fpage>65</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">18952766</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>ES</given-names></name><name><surname>Jeon</surname><given-names>JY</given-names></name><name><surname>Jekal</surname><given-names>Y</given-names></name></person-group><article-title>Improved insulin resistance, adiponectin and liver enzymes without change in plasma vaspin level after 12 weeks of exercise training among obese male adolescents</article-title><source>Korean J Obes</source><year>2011</year><volume>20</volume><issue>3</issue><fpage>138</fpage><lpage>146</lpage></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000e1;lez</surname><given-names>CR</given-names></name><name><surname>Caminos</surname><given-names>JE</given-names></name><name><surname>V&#x000e1;zquez</surname><given-names>MJ</given-names></name><name><surname>Garc&#x000e9;s</surname><given-names>MF</given-names></name><name><surname>Cepeda</surname><given-names>LA</given-names></name><name><surname>Angel</surname><given-names>A</given-names></name><etal/></person-group><article-title>Regulation of visceral adipose tissue-derived serine protease inhibitor by nutritional status, metformin, gender and pituitary factors in rat white adipose tissue</article-title><source>J Physiol</source><year>2009</year><volume>587</volume><issue>pt 14</issue><fpage>3741</fpage><lpage>3750</lpage><pub-id pub-id-type="pmid">19470778</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>1Maiorana</surname><given-names>A</given-names></name><name><surname>O'Driscoll</surname><given-names>G</given-names></name><name><surname>Goodman</surname><given-names>C</given-names></name><name><surname>Taylor</surname><given-names>R</given-names></name><name><surname>Green</surname><given-names>D</given-names></name></person-group><article-title>Combined aerobic and resistance exercise improves glycemic control and .tness in type 2 diabetes</article-title><source>Diabetes Res Clin Pract</source><year>2002</year><volume>56</volume><issue>2</issue><fpage>115</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">11891019</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunstan</surname><given-names>DW</given-names></name><name><surname>Puddey</surname><given-names>IB</given-names></name><name><surname>Beilin</surname><given-names>LJ</given-names></name><name><surname>Burke</surname><given-names>V</given-names></name><name><surname>Morton</surname><given-names>AR</given-names></name><name><surname>Stanton</surname><given-names>KG</given-names></name></person-group><article-title>Effects of a short-term circuit weight training program on glycaemic control in NIDDM</article-title><source>Diabetes Res Clin Pract</source><year>1998</year><volume>40</volume><issue>1</issue><fpage>53</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">9699091</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donnelly</surname><given-names>JE</given-names></name><name><surname>Blair</surname><given-names>SN</given-names></name><name><surname>Jakicic</surname><given-names>JM</given-names></name><name><surname>Manore</surname><given-names>MM</given-names></name><name><surname>Rankin</surname><given-names>JW</given-names></name><name><surname>Smith</surname><given-names>BK</given-names></name><etal/></person-group><article-title>American College of Sports Medicine Position Stand.Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults</article-title><source>Med Sci Sports Exerc</source><year>2009</year><volume>41</volume><issue>2</issue><fpage>459</fpage><lpage>471</lpage><pub-id pub-id-type="pmid">19127177</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigal</surname><given-names>RJ</given-names></name><name><surname>Kenny</surname><given-names>GP</given-names></name><name><surname>Wasserman</surname><given-names>DH</given-names></name><name><surname>Castaneda-Sceppa</surname><given-names>C</given-names></name><name><surname>White</surname><given-names>RD</given-names></name></person-group><article-title>Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association</article-title><source>Diabetes Care</source><year>2006</year><volume>29</volume><issue>6</issue><fpage>1433</fpage><lpage>1438</lpage><pub-id pub-id-type="pmid">16732040</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett-Connor</surname><given-names>E</given-names></name></person-group><article-title>Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus</article-title><source>Ann Intern Med</source><year>1992</year><volume>117</volume><issue>10</issue><fpage>807</fpage><lpage>811</lpage><pub-id pub-id-type="pmid">1416554</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Lehto</surname><given-names>S</given-names></name><name><surname>Penttil&#x000e4;</surname><given-names>I</given-names></name><name><surname>Py&#x000f6;r&#x000e4;l&#x000e4;</surname><given-names>K</given-names></name></person-group><article-title>Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes</article-title><source>Circulation</source><year>1993</year><volume>88</volume><issue>4 Pt 1</issue><fpage>1421</fpage><lpage>1430</lpage><pub-id pub-id-type="pmid">8403288</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>R</given-names></name><name><surname>Dagnone</surname><given-names>D</given-names></name><name><surname>Jones</surname><given-names>PJ</given-names></name><name><surname>Smith</surname><given-names>H</given-names></name><name><surname>Paddags</surname><given-names>A</given-names></name><name><surname>Hudson</surname><given-names>R</given-names></name><etal/></person-group><article-title>Reduction in obesity and related comorbid conditions after diet-induced weight loss or exerciseinduced weight loss in men.A randomized, controlled trial</article-title><source>Ann Intern Med</source><year>2000</year><volume>133</volume><issue>2</issue><fpage>92</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">10896648</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katzmarzyk</surname><given-names>PT</given-names></name><name><surname>Leon</surname><given-names>AS</given-names></name><name><surname>Rankinen</surname><given-names>T</given-names></name><name><surname>Gagnon</surname><given-names>J</given-names></name><name><surname>Skinner</surname><given-names>JS</given-names></name><name><surname>Wilmore</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Changes in blood lipids consequent to aerobic exercise training related to changes in body fatness and aerobic fitness</article-title><source>Metabolism</source><year>2001</year><volume>50</volume><issue>7</issue><fpage>841</fpage><lpage>848</lpage><pub-id pub-id-type="pmid">11436192</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>AC</given-names></name><name><surname>Haskell</surname><given-names>WL</given-names></name><name><surname>Young</surname><given-names>DR</given-names></name><name><surname>Oka</surname><given-names>RK</given-names></name><name><surname>Stefanick</surname><given-names>ML</given-names></name></person-group><article-title>Long-term effects of varying intensities and formats of physical activity on participation rates, fitness, and lipoproteins in men and women aged 50 to 65 years</article-title><source>Circulation</source><year>1995</year><volume>91</volume><issue>10</issue><fpage>2596</fpage><lpage>2604</lpage><pub-id pub-id-type="pmid">7743622</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byrne</surname><given-names>HK</given-names></name><name><surname>Wilmore</surname><given-names>JH</given-names></name></person-group><article-title>The effects of a 20-week exercise training program on resting metabolic rate in previously sedentary, moderately obese women</article-title><source>Int J Sport Nutr Exerc Metab</source><year>2001</year><volume>11</volume><issue>1</issue><fpage>15</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">11255134</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smutok</surname><given-names>MA</given-names></name><name><surname>Reece</surname><given-names>C</given-names></name><name><surname>Kokkinos</surname><given-names>PF</given-names></name><name><surname>Farmer</surname><given-names>C</given-names></name><name><surname>Dawson</surname><given-names>P</given-names></name><name><surname>Shulman</surname><given-names>R</given-names></name><etal/></person-group><article-title>Aerobic versus strength training for risk factor intervention in middle-aged men at high risk for coronary heart disease</article-title><source>Metabolism</source><year>1993</year><volume>42</volume><issue>2</issue><fpage>177</fpage><lpage>184</lpage><pub-id pub-id-type="pmid">8474314</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>PT</given-names></name><name><surname>Stefanick</surname><given-names>ML</given-names></name><name><surname>Vranizan</surname><given-names>KM</given-names></name><name><surname>Wood</surname><given-names>PD</given-names></name></person-group><article-title>The effects of weight loss by exercise or by dieting on plasma high- density lipoprotein (HDL) levels in men with low, intermediate, and normal-to-high HDL at baseline</article-title><source>Metabolism</source><year>1994</year><volume>43</volume><issue>7</issue><fpage>917</fpage><lpage>924</lpage><pub-id pub-id-type="pmid">8028519</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borghouts</surname><given-names>LB</given-names></name><name><surname>Keizer</surname><given-names>HA</given-names></name></person-group><article-title>Exercise and insulin sensitivity: a review</article-title><source>Int J Sports Med</source><year>2000</year><volume>21</volume><issue>1</issue><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">10683091</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurimae</surname><given-names>J</given-names></name><name><surname>Purge</surname><given-names>P</given-names></name><name><surname>Jurimae</surname><given-names>T</given-names></name></person-group><article-title>Adiponectin is altered after maximal exercise in highly trained male rowers</article-title><source>Eur J Appl Physiol</source><year>2005</year><volume>93</volume><issue>4</issue><fpage>502</fpage><lpage>505</lpage><pub-id pub-id-type="pmid">15618990</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamurtas</surname><given-names>AZ</given-names></name><name><surname>Theocharis</surname><given-names>V</given-names></name><name><surname>Koukoulis</surname><given-names>G</given-names></name><name><surname>Stakias</surname><given-names>N</given-names></name><name><surname>Fatouros</surname><given-names>IG</given-names></name><name><surname>Kouretas</surname><given-names>D</given-names></name><etal/></person-group><article-title>The effects of acute exercise on serum adiponectin and resistin levels and their relation to insulin sensitivity in overweight males</article-title><source>Eur J Appl Physiol</source><year>2006</year><volume>97</volume><issue>1</issue><fpage>122</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">16525810</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>BK</given-names></name><name><surname>Heutling</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Farhatullah</surname><given-names>S</given-names></name><name><surname>Adya</surname><given-names>R</given-names></name><name><surname>Keay</surname><given-names>SD</given-names></name><etal/></person-group><article-title>Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance</article-title><source>Diabetes</source><year>2008</year><volume>57</volume><issue>6</issue><fpage>1501</fpage><lpage>1507</lpage><pub-id pub-id-type="pmid">18375437</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perseghin</surname><given-names>G</given-names></name><name><surname>Price</surname><given-names>TB</given-names></name><name><surname>Petersen</surname><given-names>KF</given-names></name><name><surname>Roden</surname><given-names>M</given-names></name><name><surname>Cline</surname><given-names>GW</given-names></name><name><surname>Gerow</surname><given-names>K</given-names></name><etal/></person-group><article-title>Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects</article-title><source>N Engl J Med</source><year>1996</year><volume>335</volume><issue>18</issue><fpage>1357</fpage><lpage>1362</lpage><pub-id pub-id-type="pmid">8857019</pub-id></element-citation></ref></ref-list></back></article>